- Targeting interleukin-6 could help reduce immune-related adverse events from immunotherapy News-Medical.Net
- Scientists aim to make cancer immunotherapy safer and more effective ThePrint
- Antibody therapies could penetrate pancreatic cancer's shield if research pays off FierceBiotech
- T cell behavior informs metastatic melanoma outcomes News-Medical.Net
- View Full coverage on Google News
Targeting interleukin-6 could help reduce immune-related adverse events from immunotherapy – News-Medical.Net
ByGoogle News
May 10, 2022